ATE240303T1 - 1,2,4-triazol-3-thion verbindungen - Google Patents
1,2,4-triazol-3-thion verbindungenInfo
- Publication number
- ATE240303T1 ATE240303T1 AT99946526T AT99946526T ATE240303T1 AT E240303 T1 ATE240303 T1 AT E240303T1 AT 99946526 T AT99946526 T AT 99946526T AT 99946526 T AT99946526 T AT 99946526T AT E240303 T1 ATE240303 T1 AT E240303T1
- Authority
- AT
- Austria
- Prior art keywords
- triazole
- thione compounds
- thione
- compounds
- therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9802937A SE9802937D0 (sv) | 1998-09-01 | 1998-09-01 | Novel compounds |
PCT/SE1999/001469 WO2000012489A1 (en) | 1998-09-01 | 1999-08-27 | 1, 2, 4-triazole-3-thione compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE240303T1 true ATE240303T1 (de) | 2003-05-15 |
Family
ID=20412435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99946526T ATE240303T1 (de) | 1998-09-01 | 1999-08-27 | 1,2,4-triazol-3-thion verbindungen |
Country Status (8)
Country | Link |
---|---|
US (1) | US20020086862A1 (de) |
EP (1) | EP1109790B1 (de) |
JP (1) | JP2002525281A (de) |
AT (1) | ATE240303T1 (de) |
AU (1) | AU5892399A (de) |
DE (1) | DE69907926T2 (de) |
SE (1) | SE9802937D0 (de) |
WO (1) | WO2000012489A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2361003A (en) * | 2000-04-07 | 2001-10-10 | Astrazeneca Ab | Novel compounds |
MXPA03000500A (es) * | 2000-07-18 | 2003-06-24 | Smithkline Beecham Corp | Uso de antagonistas del receptor de isoleucina 8 en el tratamiento de infecciones por virus. |
WO2004069809A1 (en) * | 2003-02-03 | 2004-08-19 | Janssen Pharmaceutica N.V. | Mercaptoimidazoles as ccr2 receptor antagonists |
US7276050B2 (en) * | 2004-03-02 | 2007-10-02 | Alan Franklin | Trans-scleral drug delivery method and apparatus |
AU2005231123A1 (en) * | 2004-03-08 | 2005-10-20 | Wyeth | Ion channel modulators |
RU2007108289A (ru) * | 2004-08-11 | 2008-09-20 | Янссен Фармацевтика Н.В. (Be) | Меркаптоимидазолы, предназначенные для использования в качестве антагонистов рецептора ccr2 |
FR2883875A1 (fr) * | 2005-04-01 | 2006-10-06 | Galderma Res & Dev | Nouveaux inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique |
WO2006103119A2 (en) * | 2005-04-01 | 2006-10-05 | Galderma Research & Development | Tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics |
US20100317515A1 (en) * | 2007-12-19 | 2010-12-16 | Basf Se | Azolylmethyloxiranes, use Thereof and Agents Containing the Same |
EP2224812A2 (de) * | 2007-12-19 | 2010-09-08 | Basf Se | Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel |
CN101952279A (zh) * | 2007-12-19 | 2011-01-19 | 巴斯夫欧洲公司 | 唑基甲基环氧乙烷、其应用和包含它们的组合物 |
TWI487705B (zh) | 2009-12-17 | 2015-06-11 | Lundbeck & Co As H | 作為pde10a酵素抑制劑之雜芳香族芳基三唑衍生物 |
US9505728B2 (en) | 2012-03-09 | 2016-11-29 | Inception 2, Inc. | Triazolone compounds and uses thereof |
PE20151521A1 (es) | 2012-12-20 | 2015-11-25 | Inception 2 Inc | Compuestos de triazolona y usos de los mismos |
CN103012233B (zh) * | 2012-12-26 | 2015-08-26 | 华润赛科药业有限责任公司 | 一种n-(氨基硫代甲基)-5-氧代-1-丙基-2-吡咯烷乙酰胺的制备方法 |
MX2016002795A (es) | 2013-09-06 | 2016-05-26 | Inception 2 Inc | Compuestos de triazolona y usos de los mismos. |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW467902B (en) * | 1996-07-31 | 2001-12-11 | Bristol Myers Squibb Co | Diphenyl heterocycles as potassium channel modulators |
-
1998
- 1998-09-01 SE SE9802937A patent/SE9802937D0/xx unknown
-
1999
- 1999-08-27 AT AT99946526T patent/ATE240303T1/de not_active IP Right Cessation
- 1999-08-27 AU AU58923/99A patent/AU5892399A/en not_active Abandoned
- 1999-08-27 JP JP2000571050A patent/JP2002525281A/ja active Pending
- 1999-08-27 DE DE69907926T patent/DE69907926T2/de not_active Expired - Fee Related
- 1999-08-27 EP EP99946526A patent/EP1109790B1/de not_active Expired - Lifetime
- 1999-08-27 WO PCT/SE1999/001469 patent/WO2000012489A1/en active IP Right Grant
-
2001
- 2001-12-10 US US10/006,245 patent/US20020086862A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE69907926T2 (de) | 2004-02-19 |
EP1109790A1 (de) | 2001-06-27 |
WO2000012489A1 (en) | 2000-03-09 |
JP2002525281A (ja) | 2002-08-13 |
EP1109790B1 (de) | 2003-05-14 |
US20020086862A1 (en) | 2002-07-04 |
DE69907926D1 (de) | 2003-06-18 |
SE9802937D0 (sv) | 1998-09-01 |
AU5892399A (en) | 2000-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69905170D1 (en) | Thiazolopyrimidinderivate | |
SE9704546D0 (sv) | Novel compounds | |
TR200100054T2 (tr) | Paroksetin metansülfonat | |
DK0960107T3 (da) | 6-Thiosubstituerede paclitaxeler | |
SE9704544D0 (sv) | Novel compounds | |
PT1036058E (pt) | Deribvados de adamantano | |
TNSN97010A1 (fr) | Cyclopentanopyridyl-oxazolidinones contenant des heteroatomes. | |
ATE240303T1 (de) | 1,2,4-triazol-3-thion verbindungen | |
YU13301A (sh) | Muskarinski agonisti i antagonisti | |
AP1703A (en) | Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same. | |
IL101358A0 (en) | Crystalline tiagabine hydrochloride monohydrate,its preparation and pharmaceutical compositions containing it | |
IL131407A0 (en) | Tetrahydropyrido compounds medicaments containing the same and the use thereof | |
ATE500269T1 (de) | Verbindungen mit wachstumshormon-freisetzenden eigenschaften | |
AP2001002369A0 (en) | Pharmaceutical complex. | |
WO2002066492A3 (fr) | Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques. | |
IT1290910B1 (it) | 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive | |
EP1011329A4 (de) | 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele | |
RS47804A (en) | 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof | |
ATE272651T1 (de) | Verbindungen mit wachstumshormon-freisetzender eigenschaft | |
ZA981275B (en) | Disubstituted bicyclic heterocycles, the preparation and the use thereof as pharmaceutical compositions. | |
TWI231815B (en) | Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents | |
ZA986139B (en) | Sulphonamide compounds, processes for their preparation, pharmaceutical compositions containing the same and their use in therapy. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |